The metabolic shift from OXPHOS to glycolysis due to genetic ablation of p32 has been reported in breast cancer cells10 and dendritic cells43, and similarly the p32−/− MEFs showed a glycolytic metabolic shift (Fig. 7a,b). The gene discussed is C1QBP; the disease is breast cancer.